POLARITYTE, INC.: Nasdaq/NYSE listing notice — PolarityTE receives Nasdaq deficiency notice for bid price below $1.00 per share

POLARITYTE, INC.

Nasdaq notified PolarityTE on Oct 26, 2022 that its common stock bid price closed below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until April 24, 2023, to regain compliance with the Minimum Bid Price Requirement.
If compliance not achieved by April 24, 2023, may be eligible for an additional 180-day period if it meets other listing standards.
To qualify for extra time, company must notify Nasdaq of intent to cure via reverse split, if needed.
Failure to regain compliance or meet conditions could result in delisting from Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

POLARITYTE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

October 26, 2022, PolarityTE, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided an

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001493152-22-029855

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.